Jian-guo Li-Jianguo
2 Yabao Road
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical features, triggers, and risk factors of severe gastrointestinal involvement in anti-NXP2-positive juvenile dermatomyositis: a retrospective cohort study.
Journal: Pediatric rheumatology online journal
Published: February 01, 2026
Clinical characteristics of coronary artery involvement in children with Behcet's syndrome.
Journal: Clinical rheumatology
Published: July 28, 2024
Elevated type I IFN signalling directly affects CD8+ T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients.
Journal: Journal of autoimmunity
Published: September 29, 2023
Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis.
Journal: Pediatric rheumatology online journal
Published: September 18, 2020
Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis.
Journal: Annals of the rheumatic diseases
Published: July 20, 2020
Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
Journal: Pediatric rheumatology online journal
Published: June 19, 2020
Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children.
Journal: Pediatric rheumatology online journal
Published: June 06, 2020
Ruxolitinib in Alleviating the Cytokine Storm of Hemophagocytic Lymphohistiocytosis.
Journal: Pediatrics
Published: December 30, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026